Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Lung Cancer Excellence Forum

Lung Cancer
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Dr Sun, Dr Borghaei
Debates and Roundtables
Roundtable Highlight: Dr Borghaei, Dr Sun Support Next-Gen Liquid Biopsy Testing to Detect KRAS Mutations in NSCLC
01/07/2022
In this featured virtual roundtable highlight, Lova Sun, MD and Hossein Borghaei, DO share optimal testing practices for the detection of KRAS G12C sensitive mutations in patients with non-small-cell lung cancer.
In this featured virtual roundtable highlight, Lova Sun, MD and Hossein Borghaei, DO share optimal testing practices for the detection of KRAS G12C sensitive mutations in patients with non-small-cell lung cancer.
In this featured virtual...
01/07/2022
Oncology
Charu Aggarwal, MD
Podcasts
Dr Aggarwal Discusses Plasma-Based NGS for Patients With Nonsquamous NSCLC
11/22/2021
Charu Aggarwal, MD, discusses incorporating plasma-based next-generation sequencing to improve guideline-concordant molecular testing in patients with newly diagnosed metastatic nonsquamous NSCLC.
Charu Aggarwal, MD, discusses incorporating plasma-based next-generation sequencing to improve guideline-concordant molecular testing in patients with newly diagnosed metastatic nonsquamous NSCLC.
Charu Aggarwal, MD, discusses...
11/22/2021
Oncology
Melina Marmarelis, MD, Lova Sun, MD, and Hossein Borghaei, DO
Debates and Roundtables
Expert Roundtable: Melina Marmarelis, MD, and Colleagues Talk Treatment of KRAS G12C NSCLC
11/01/2021
In this virtual roundtable, Dr Marmarelis convened with Lova Sun, MD, and Hossein Borghaei, DO, to discuss the treatment of patients with lung cancer and KRAS G12C sensitive mutations.
In this virtual roundtable, Dr Marmarelis convened with Lova Sun, MD, and Hossein Borghaei, DO, to discuss the treatment of patients with lung cancer and KRAS G12C sensitive mutations.
In this virtual roundtable, Dr...
11/01/2021
Oncology
Edgardo Santos, Luis Raez, Federico Albrecht, Mark Socinski, John Heymach
Debates and Roundtables
Expert Roundtable: The Management and Care of EGFR Patients
10/28/2021
In part three of this virtual roundtable discussion, a panel of experts sat down with Oncology Learning Network to discuss the management and care of EGFR patients.
In part three of this virtual roundtable discussion, a panel of experts sat down with Oncology Learning Network to discuss the management and care of EGFR patients.
In part three of this virtual...
10/28/2021
Oncology
Edgardo Santos, Luis Raez, Federico Albrecht, Mark Socinski, John Heymach
Debates and Roundtables
Expert Roundtable: Biologic Differences Among EGFR/ERBB1 Mutations in Patients With Lung Cancer
10/27/2021
In part two of this virtual roundtable discussion, Dr Edgardo Santos et al discuss the biologic differences of EGFR and ERBB1 mutations observed in patients with lung cancer.
In part two of this virtual roundtable discussion, Dr Edgardo Santos et al discuss the biologic differences of EGFR and ERBB1 mutations observed in patients with lung cancer.
In part two of this virtual...
10/27/2021
Oncology
Edgardo Santos, Luis Raez, Federico Albrecht, Mark Socinski, John Heymach
Debates and Roundtables
Expert Roundtable: OS Rates Among Patients With EGFR Mutations in the TKI Era
10/27/2021
In part one of this virtual roundtable discussion, Edgardo Santos, MD; Luis Raez, MD; Federico Albrecht, MD; Mark Socinski, MD; and John Heymach, MD, PhD, discuss the rates of overall survival among patients with EGFR mutations in the TKI era.
In part one of this virtual roundtable discussion, Edgardo Santos, MD; Luis Raez, MD; Federico Albrecht, MD; Mark Socinski, MD; and John Heymach, MD, PhD, discuss the rates of overall survival among patients with EGFR mutations in the TKI era.
In part one of this virtual...
10/27/2021
Oncology
MalindaItchins
Videos
Dr Itchins Discusses Intermin Results From the ALKternate Clinical Trial
10/19/2021
Malinda Itchins, FRACP, PhD, Royal North Shore Hospital, Sydney, Australia, sits down with Oncology Learning Network to discuss the preliminary analysis of the ALKternate clinical trial.
Malinda Itchins, FRACP, PhD, Royal North Shore Hospital, Sydney, Australia, sits down with Oncology Learning Network to discuss the preliminary analysis of the ALKternate clinical trial.
Malinda Itchins, FRACP, PhD,...
10/19/2021
Oncology
Shirish Gadgeel
Videos
Dr Gadgeel Discusses Pembrolizumab, Platinum-Based Chemo in EGFR/ALK-Positive NSCLC
09/29/2021
Shirish Gadgeel, MD, Henry Ford Health System, Detriot, MI, shares insight on pembrolizumab in combination with platinum-based chemotherapy in recurrent EGFR/ALK-Positive non-small cell lung cancer.
Shirish Gadgeel, MD, Henry Ford Health System, Detriot, MI, shares insight on pembrolizumab in combination with platinum-based chemotherapy in recurrent EGFR/ALK-Positive non-small cell lung cancer.
Shirish Gadgeel, MD, Henry Ford...
09/29/2021
Oncology
MarmarelisSunBorghaei
Debates and Roundtables
Expert Roundtable: Overcoming Resistance in KRAS G12C-Mutated NSCLC
09/29/2021
In part two of this virtual roundtable discussion, experts sat down with Oncology Learning Network to discuss overcoming resistance to KRAS G12C sensitive mutations in patients with lung cancer.
In part two of this virtual roundtable discussion, experts sat down with Oncology Learning Network to discuss overcoming resistance to KRAS G12C sensitive mutations in patients with lung cancer.
In part two of this virtual...
09/29/2021
Oncology
MarmarelisSunBorghaei
Debates and Roundtables
Expert Roundtable: Exploring the Treatment Landscape of KRAS G12C-Mutated NSCLC
09/29/2021
In part one of this virtual roundtable discussion, experts sat down with Oncology Learning Network to discuss KRAS G12C sensitive mutations in patients with lung cancer.
In part one of this virtual roundtable discussion, experts sat down with Oncology Learning Network to discuss KRAS G12C sensitive mutations in patients with lung cancer.
In part one of this virtual...
09/29/2021
Oncology

Advertisement

Section Editor

cjl
Corey J. Langer, MD
Abramson Cancer Center Perelman School of Medicine, University of Pennsylvania

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement